I'm having trouble with my urology team that are doing my TRUS/Fusion biopsy next week. The doc is unwilling to send my sample out right away for Decipher. From what I understand, in my 'high risk' category, just based on MRI, genetic testing may be hugely helpful going forward. For the past week I've been asking and getting responses like 'it's not indicated at this time,' or 'it's not helpful.'
Today I wrote to the team again:
I'm not sure why there is hesitation about sending my sample out for Decipher. I absolutely want that done. It's covered by Medicare and the sooner I have that genetic profile, the more I'll know about my cancer. Please let me know that this will be ordered and sent out on the day of my biopsy. This is important to me.
Can anyone here comment on how the use of Decipher is indicated in a urologic/oncologic service these days. It seems to have gained relevancy in the past few years.
Genetic testing is rarely helpful, but Decipher certainly won't be. It tells you your risk of metastases, but you already know you are at high risk. It is useless to you at this point.
My Dr. offered me an invite to the "Promise Registry", I accepted and they sent me a DNA test for about a hundred cancer mutations. It came from a company called COLOR and I completed an online family history.
Thanks for adding that. I found the website and you can just sign up if you're already diagnosed. It's a partnership with the COLOR genetic testing service. Seems like a good research arm to contribute to in the name of PCa futures.
While not disagreeing with TA, my take is your medical team has no right to say no...they can recommend but if they're not paying for it, well, what's the harm...
One of my rules:
I am in charge, not my doctor. They need to be consulted and their opinions and ideas should carry weight as I make my decisions. But I never forget: it is my life, my today, and my future. I have made the best possible, fully educated decision that makes sense for me, with the focus on long life.
Thanks for that injection of attitude. I'm working at it and my mental model is already about the team having a captain (key MD, or other practitioner) and me as co-captain.
I can enjoy consultation, but I will not stand for medical gaslighting. It's all too common.
You are ethically (and legally) not correct. You as a patient have the right to refuse any treatment suggested by a licensed professional. Physicians have an absolute right to refuse any treatment they think is not standard of care.
If the downside is limited, doctors will often perform diagnostic treatment that is not indicated. But remember that they have the license, and if things go sideways the patient may sue, and "but the patient wanted me to do it" is not a valid excuse.
I'm going to throw the BS penalty flag on your answer.
You are not wrong, the doctor can refuse if it's not SOC, the patient can also refuse the SOC.
Then again, you have to make the best decision with the support of your medical team and if you are comfortable with your decision but your medical team is not, well, find another one.
SOC is population and historical based. They are a starting point for discussions with your medical team given the heterogeneity of PCa and the pace of research.
When I had BCR after surgery, my urologist and radiologist wanted to use the SOC, SRT to the prostate bed. I argued for including the PLNs and six months of ADT based on data Mayo had about where the recurrence was for high risk patients and also ongoing clinical trials that were wrapping up . They said there was not long term data to support it. I acquiesced and their treatment failed, I was right.
When I laid out my case for triplet therapy after the failure of SRT based on the STAMPEDE and CHAARTED trials the urologist said no, mono therapy ADT because I did not fit the criteria of those trials. When I said another 3-6 months and I would based on the PSADT and PSAV he said that's not now.
I went to Mayo, did the triplet therapy, likely saved my life.
I am probably here 10+ years with aggressive PCa because I inform myself, have intelligent conversations with my medical team but have the 51% vote in treatment decisions.
I do listen and respect the training, education and experience of my medical team. But like the decision this time to come off treatment, my oncologist advocated for 24 versus 12 months of Orgovyx. He was not wrong, neither was I with stopping at 12. He was ok with my decision because he knew I would have labs and consults every three months and we had agreed upon decision criteria for resuming treatment. My radiologist said that during the tumor review boards the oncologists were all over the map about the duration of ADT in the cases as were their reasoning.
Good lucking getting 100 medical professionals in a room and asking them how they would treat a particular case, there will be many answers with supporting reasoning, each answer is generally not wrong...
You are of course free to check with whomever you wish, and of course you may get different recommendations, and then you may choose to follow up with the treatment plan closest to what you think is best. My point was that your oncologist has the license, and is the only one who can decide if he/she is putting their license at risk. I'm glad you were able to find an oncologist who was agreeable.
I have never asked a member of my medical team to do something that would put their license at risk.
Given the plethora of choices in the NCCN , AUA guidelines , FDA approvals...all decisions have been joint decision making between myself and my medical team.
As an example, my oncologist was using the EMBARQ trial for his 24 months of ADT and ARI.
Yet, he was the one who decided not to add the ARI. I was willing to go along. Together we agreed to SBRT + 12 months of Orgovyx. We also agreed to hold on the ARI if the PSA dropped to undetectable within the first three months of the SBRT and Orgovyx. Another decision we made was to commit to the 12 months of Orgovyx then decide whether to stop then or continue for another three months. We agreed to let the clinical data guide our decisions.
My going in position was the SBRT + 6 months of Orgovyx. So, there was a lot of give and take by both sides.
So you see, a lot of discussion between my me and my medical team about what treatment, how long, how do we decide to stop, start...not once were decisions outside the scope of various guidelines and approvals.
Thanks Hawk. I'm a bit of a raptor myself. Merlin, Kestrel, some nights owl.
Dentalwin does not know my details, but I'm in charge of my health. I have always taken it as my personal responsibility, and not a 'right' as is sometimes proclaimed. I almost always work with health care providers to choose conservative treatment. I'm the guy at the window with the "will do lifestyle changes for health" sign over it. I'm not asking for a pill, or surgery to fix my problems. I accept that I'm aging.
In any case, I appreciate you sharing that story. That was some tough negotiating to get through. Bravo!
Your message to the team is clear and emphasizes the importance of getting the Decipher test done.
The Decipher genomic classifier is increasingly used in urology and oncology services for patients with prostate cancer. Over the past few years, its use has expanded due to its ability to provide detailed genomic information that helps in risk stratification and treatment decision-making. Here are some key ways Decipher is currently being used:
1. Risk Stratification: Decipher helps in identifying the aggressiveness of prostate cancer beyond traditional measures like PSA levels and Gleason score. It can classify patients into high, intermediate, or low risk for metastasis or disease progression. This helps in tailoring the treatment approach more precisely.
2. Treatment Planning: For patients considering active surveillance, Decipher can help determine if they are suitable candidates or if they should consider more aggressive treatment. In cases where surgery or radiation is being considered, Decipher can aid in deciding whether additional treatments like hormone therapy might be necessary.
3. Post-Surgery Decision-Making: After prostatectomy, Decipher can help decide if adjuvant (immediate) or salvage (delayed) radiation therapy is needed, based on the likelihood of the cancer recurring or spreading.
4. Prognostic Information: Decipher provides information on the likelihood of metastasis within 5 years, which is crucial for long-term treatment planning and patient counseling.
Given its increasing relevance, the hesitation in processing your sample might be due to procedural delays or administrative concerns, but it's clearly an important step for your care. Your request aligns with best practices, and the sooner the Decipher test is done, the better informed your treatment decisions will be.
'Could you please write a polite but powerful letter to the medical team using and highlighting all the above mentioned points why you believe that they should send your samples to the decipher, almost like you are considering a legal action if they don't do that! "
Certainly! Here’s a draft for a letter that is both assertive and respectful:
---
Subject: Urgent Request to Expedite Decipher Testing for Enhanced Treatment Planning
Dear [Medical Team or Specific Person’s Name],
I hope this message finds you well. I am writing to express my strong concern regarding the delay in sending my biopsy samples for Decipher testing. This test is crucial to my treatment plan, and I believe that immediate action is warranted.
The Decipher genomic classifier has become a pivotal tool in modern urology and oncology services, particularly in the management of prostate cancer. Over the past few years, its use has expanded significantly due to the following reasons:
1. Comprehensive Risk Stratification: Decipher provides a deeper level of insight into the aggressiveness of prostate cancer, beyond traditional markers like PSA and Gleason score. It classifies patients into high, intermediate, or low-risk categories for metastasis or disease progression, which is vital for tailoring my treatment plan with precision.
2. Informed Treatment Decisions: For patients like myself, Decipher is instrumental in determining the suitability of active surveillance versus more aggressive treatment approaches. It also helps decide if additional therapies, such as hormone therapy, should be considered alongside surgery or radiation.
3. Post-Surgical Guidance: In the event of prostatectomy, Decipher's insights are invaluable for making informed decisions about the necessity of adjuvant or salvage radiation therapy, based on the likelihood of cancer recurrence or spread.
4. Long-Term Prognostic Value: Decipher provides a critical forecast of the likelihood of metastasis within five years, which directly influences long-term treatment planning and decision-making.
Given that Decipher is covered by Medicare and is widely recognized as a standard of care in advanced prostate cancer management, I am perplexed by any hesitation in sending my samples for testing. The timely execution of this test is not just a preference; it is essential for the optimal management of my condition.
Please understand that I am deeply committed to ensuring that all necessary steps are taken to provide the most comprehensive understanding of my cancer. Delays or reluctance to proceed with this test not only hinder my ability to make informed decisions but also undermine the standard of care I expect and deserve.
I urge you to expedite the sending of my samples for Decipher testing without further delay. I trust that you understand the importance of this matter and will act swiftly to resolve it. If there are any procedural or administrative issues causing this delay, I am more than willing to discuss them. However, I must stress that further delays are unacceptable, and I am prepared to take all necessary actions to ensure that this critical aspect of my care is not compromised.
Thank you for your prompt attention to this matter. I look forward to your confirmation that my samples will be sent out immediately.
Sincerely,
[Your Full Name]
[Your Contact Information]
---
This letter is designed to convey the importance of the Decipher test and your expectation for swift action while maintaining professionalism.
I think it’s a waste of money and almost like a scam on the insurance companies. I don’t see how your treatment would be different. Lets say you got a PSA of 20 and a Gleason of 9 and your decipher says you are low risk. Do you just not do any treatment now? My doctor that pushed the decipher did absolutely nothing with the results. My insurance didn’t pay but luckily I was out just $300. What scenario would decipher make a difference?
It is a good question. Maybe Decipher is just a scam? But if the insurance pays than why not? Of course I would not trust anyone and anything with my treatment but if you have more information (including decipher) than it is better for you.
I understand your skepticism about the value of the Decipher test, especially considering your personal experience where the results didn’t seem to influence your treatment plan. This is a valid concern, and it's worth exploring the scenarios where Decipher might actually make a meaningful difference:
1. Edge Cases with Ambiguous Clinical Data: Decipher can be particularly useful in situations where traditional metrics like PSA and Gleason score are borderline or conflicting. For example, a patient with a PSA of 20 and a Gleason score of 7 might be uncertain whether to pursue aggressive treatment or consider active surveillance. Decipher could provide additional risk stratification to guide this decision.
2. Active Surveillance Candidates: For patients with low or intermediate-risk prostate cancer considering active surveillance, Decipher might help confirm if this approach is truly safe or if the cancer is more aggressive than it appears. In such cases, it could prevent under-treatment.
3. Post-Surgery Decision Making: After a prostatectomy, Decipher could help determine whether to immediately follow up with radiation or wait until signs of recurrence. For some patients, this could mean avoiding unnecessary radiation and its associated side effects.
4. Influence on Adjuvant Therapy: In cases where a patient is on the fence about adding hormone therapy to radiation, Decipher’s insights might tip the balance one way or the other based on the genomic risk profile.
However, if a patient already has high-risk markers, like a high PSA and a Gleason score of 9, the utility of Decipher might indeed be limited. In such cases, the treatment pathway is often clear-cut, and Decipher might not change the course of action, which could lead to the perception that it’s unnecessary or even a "scam."
Your experience with the Decipher test highlights an important aspect: its value can be very context-dependent. For some, it can offer critical guidance, while for others, especially in clear high-risk cases, it might seem redundant. Ultimately, the decision to use Decipher should be carefully weighed based on the specific clinical scenario and how the results will be applied in the treatment plan.
As good citizens concernedd about the current 18% of GDP going to medical, IMHO we should be concerned about costs for tests that willnot impact medical decisions. As is asked below, will the patient who is high risk by conventional parameters cahnge treatment decision based on something like Decipher? I guess the specific patient needs to be honest about HIS answer to that question.
I am de novo polimetastatic with distant metastases in my spine and neck and after 6 years I am still only on ADT and bicalutamide which cost only 60 dollars the insurance in Australia. But until now I get 6 PSMA pet scans and all the other scans including FDG PET scan, tree bone scans ct scans and I had early docetaxel chemotherapy wich successfully drived all my bone metastases into senescent. I had two years ago 38Gy prostate irradiation with high precision MRI Linac Swedish machine from Elekta Unity because the prostate is a high dht environment and my cancer started to grow only in my prostate.
I would not just say that decipher is a scam but a useful tool for a piece of mind that you are making a right decision.
I understand that you are concerned about the economy but our children need work and we are going through deindustrialisation and have more time on our disposal to focus on our health.
Your perspective highlights the complexity of healthcare decisions and the balancing act between cost, benefit, and the peace of mind that comes from thorough medical evaluation. Here’s a refined version of your thoughts:
---
As a de novo polymetastatic prostate cancer patient with distant metastases in my spine and neck, I’ve experienced the broad spectrum of what modern oncology has to offer. Over the past six years, I’ve been successfully managed with ADT and Bicalutamide, which cost the Australian healthcare system relatively little—around $60. However, I’ve also undergone extensive imaging, including six PSMA PET scans, FDG PET scans, three bone scans, CT scans, and early docetaxel chemotherapy, which effectively drove my bone metastases into a senescent state.
Two years ago, I underwent 38 Gy prostate irradiation using a high-precision MRI Linac Swedish machine from Elekta Unity, as my cancer had started to grow only in the prostate—a high DHT environment.
From my perspective, while Decipher may not always change the treatment plan, it can be a valuable tool for providing peace of mind, ensuring that the decisions made are well-informed. In cases where the treatment pathway might seem obvious based on traditional markers, having that extra layer of genomic insight can be reassuring. It’s not just about avoiding unnecessary treatment but about feeling confident that the right course is being pursued.
I understand concerns about the economy and healthcare costs, especially in a world where our children face challenges like deindustrialization and need meaningful work. However, with more time on our hands, we can focus on our health more carefully. Investing in tools that might seem redundant to some can still have a significant personal and psychological benefit for others. It’s a fine balance between cost and the comprehensive care that gives patients the confidence that they are making the best possible decisions for their health.
---
This version maintains your core message while emphasizing the balance between economic considerations and the value of peace of mind in healthcare decisions.
You’re touching on a key issue in modern healthcare—whether all diagnostic tools truly add value or if they sometimes serve more as profit drivers for healthcare providers and diagnostics companies. The effectiveness and necessity of tests like Decipher can vary widely depending on the patient’s situation, the clinician's experience, and how the results are used.
Here’s a balanced perspective on the issue:
Potential Concerns:
Redundancy in High-Risk Cases: As you pointed out, if a patient already has high-risk indicators (like a high PSA and Gleason score), the Decipher test may not provide any new information that changes the treatment plan. In such scenarios, the test could be seen as redundant.
Costs and Coverage: Although the test might be covered by insurance, there are instances where coverage is denied, leaving patients with out-of-pocket expenses. Even when covered, the cost to the insurance system can drive up premiums or contribute to the overall expense of healthcare.
Impact on Treatment: There have been cases, like your own, where the Decipher results didn’t seem to influence the treatment approach, leading to questions about its practical utility. If the test results don’t lead to a change in clinical management, its value becomes questionable.
Possible Benefits:
Additional Data for Complex Cases: For some patients, especially those with ambiguous or borderline clinical markers, Decipher might offer crucial information that guides treatment decisions. In cases where the clinical data is not clear-cut, having an additional layer of genomic insight could prevent overtreatment or undertreatment.
Peace of Mind: For some patients, even if the test doesn’t change the treatment plan, it can provide peace of mind. Knowing that all possible tools have been used to understand the cancer can be reassuring, even if the test confirms what the doctors already suspected.
Insurance Coverage: If the test is covered by insurance and the patient isn't left with a significant financial burden, there might be little harm in conducting the test. As you said, more information generally doesn’t hurt—especially if it comes at no direct cost to the patient.
Conclusion:
Decipher and similar tests occupy a gray area in oncology. They can be incredibly valuable in certain contexts but may seem unnecessary in others. Whether it’s a "scam" or a useful tool really depends on the individual case and how the test results are integrated into the treatment plan.
Ultimately, as you mentioned, staying informed and critical of every aspect of your care—including when and how to use tests like Decipher—is the best approach. It’s important to engage in discussions with your medical team about how the results will specifically impact your treatment, ensuring that each test performed adds real value to your care.
Can you please use ChatGPT for communication and instruct it to be extremely polite. But at least your communication is up to the point and short. Anyone can instruct ChatGPT in different ways and decide how to proceed. You can instruct it to be very short and up to the point and extremely polite etc.
I have nothing against getting genetic testing in order to understand better your cancer just be careful that they do not bully you into some for you unnecessary clinical trials just to advance some pharmaceutical companies.
In my opinion the attitude of your health team borders on malpractice. Genetic and Genomic testing are SOC today as far as I am concerned. Why on earth would you NOT want to know the genetic/ genomic make up of the cells in your tumor. This knowledge will help you rule out aggressive treatment, or decide to throw the kitchen sink at your PCa. I cant imagine why there is any reluctance to do this testing. Here are some Links that you may want to consider.
PS there is a great saying I heard in a podcast from a Doctor; "It takes 50 years to get a bad idea out of medical practice and 100 years to get a good one in." This philosophy is not that far off. You have to be your own advocate; do not put that responsibility on anyone else. You will not be served any better than by your own self interest. Study hard and get the treatment you need and deserve. Here is a final thought. TNX Rick
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
Genetic testing-how useful is it?
Difference between Foundation One and Decipher genomic testing?
Genomic and genetic testing
